Efficacy of N-acetylcysteine in preventing amphotericin B induced acute kidney injury
Objectives: Previously, in an animal study we showed that N-acetylcysteine (NAC) could decrease deoxycholate amphotericin B (DAmB) induced renal tubular apoptosis. In this clinical study, we aimed to evaluate the efficacy of NAC in preventing acute kidney injury (AKI) in febrile neutropenic patients...
Gespeichert in:
| Veröffentlicht in: | Marmara Medical Journal 2016-01, Vol.29 (2), p.73 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | 73 |
| container_title | Marmara Medical Journal |
| container_volume | 29 |
| creator | Erturk Sengel, Buket Tukenmez Tigen, Elif Toptas, Tayfur Atagunduz, Isik Tuglular, Ayse Tulin Ergönül, Mehmet Onder Odabası, Zekaver |
| description | Objectives: Previously, in an animal study we showed that N-acetylcysteine (NAC) could decrease deoxycholate amphotericin B (DAmB) induced renal tubular apoptosis. In this clinical study, we aimed to evaluate the efficacy of NAC in preventing acute kidney injury (AKI) in febrile neutropenic patients with invasive pulmonary aspergillosis treated with DAmB.Patients and Methods: Thirty-three patients were included in the study. 17 patients were randomly placed into the DAmB group and 16 were randomly placed into the DAmB plus NAC group.Results: The characteristics of patients, durations and cumulative doses of DAmB, concurrent nephrotoxic drugs and basal serum creatinine (SCr) levels of patients were similar. Occurrence of a 1.5 fold or greater increase in the concentration of basal SCr and serum electrolytes were observed prospectively. The overall AKI was found in 13 patients (76.4%) in DAmB group and 6 patients (37.5%) in combination group (P = 0.024). No significant difference was observed in hypokalemia incidence between the groups (87.5 % in combination vs. 94.1 % in DAmB only groups).Conclusion: This clinical pilot study showed that NAC may be a promising anti-oxidant agent to decrease DAmB-induced AKI in febrile neutropenic patients.Keywords: Amphotericin |
| doi_str_mv | 10.5472/MMJoa.2902.02 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2718731126</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2718731126</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260t-e2a805e557f4e0a3b9de79c3e366a58b85ecfe665b96adba55e713411d4abba83</originalsourceid><addsrcrecordid>eNotkEtPwzAQhC0EEqVw5G6Js4sfsRMfoSovtXChZ8tx1uDQJsFxkPLvSSmnWc2MdqQPoWtGFzLL-e1m89LaBdeULyg_QTMmqCY6U_p0uinThOmMnaOLvq8plQXVaoa2K--Ds27ErcevxDpI486NfYLQAA4N7iL8QJNC84HtvvtsE8TgJv9-CqvBQYWtGxLgr1A1ME5mPcTxEp15u-vh6l_naPuwel8-kfXb4_Pybk0cVzQR4LagEqTMfQbUilJXkGsnQChlZVEWEpwHpWSpla1KKyXkTGSMVZktS1uIObo5_u1i-z1An0zdDrGZJg3PWZELxriaWuTYcrHt-wjedDHsbRwNo-ZAzvyRMwdyhnLxC_NiYqQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2718731126</pqid></control><display><type>article</type><title>Efficacy of N-acetylcysteine in preventing amphotericin B induced acute kidney injury</title><source>EZB Electronic Journals Library</source><creator>Erturk Sengel, Buket ; Tukenmez Tigen, Elif ; Toptas, Tayfur ; Atagunduz, Isik ; Tuglular, Ayse Tulin ; Ergönül, Mehmet Onder ; Odabası, Zekaver</creator><creatorcontrib>Erturk Sengel, Buket ; Tukenmez Tigen, Elif ; Toptas, Tayfur ; Atagunduz, Isik ; Tuglular, Ayse Tulin ; Ergönül, Mehmet Onder ; Odabası, Zekaver</creatorcontrib><description>Objectives: Previously, in an animal study we showed that N-acetylcysteine (NAC) could decrease deoxycholate amphotericin B (DAmB) induced renal tubular apoptosis. In this clinical study, we aimed to evaluate the efficacy of NAC in preventing acute kidney injury (AKI) in febrile neutropenic patients with invasive pulmonary aspergillosis treated with DAmB.Patients and Methods: Thirty-three patients were included in the study. 17 patients were randomly placed into the DAmB group and 16 were randomly placed into the DAmB plus NAC group.Results: The characteristics of patients, durations and cumulative doses of DAmB, concurrent nephrotoxic drugs and basal serum creatinine (SCr) levels of patients were similar. Occurrence of a 1.5 fold or greater increase in the concentration of basal SCr and serum electrolytes were observed prospectively. The overall AKI was found in 13 patients (76.4%) in DAmB group and 6 patients (37.5%) in combination group (P = 0.024). No significant difference was observed in hypokalemia incidence between the groups (87.5 % in combination vs. 94.1 % in DAmB only groups).Conclusion: This clinical pilot study showed that NAC may be a promising anti-oxidant agent to decrease DAmB-induced AKI in febrile neutropenic patients.Keywords: Amphotericin</description><identifier>ISSN: 1019-1941</identifier><identifier>EISSN: 1309-9469</identifier><identifier>DOI: 10.5472/MMJoa.2902.02</identifier><language>eng</language><publisher>Istanbul: Marmara University</publisher><subject>Kidneys ; Neutropenia</subject><ispartof>Marmara Medical Journal, 2016-01, Vol.29 (2), p.73</ispartof><rights>2016. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://dergipark.org.tr/en/pub/marumj/about-journal</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Erturk Sengel, Buket</creatorcontrib><creatorcontrib>Tukenmez Tigen, Elif</creatorcontrib><creatorcontrib>Toptas, Tayfur</creatorcontrib><creatorcontrib>Atagunduz, Isik</creatorcontrib><creatorcontrib>Tuglular, Ayse Tulin</creatorcontrib><creatorcontrib>Ergönül, Mehmet Onder</creatorcontrib><creatorcontrib>Odabası, Zekaver</creatorcontrib><title>Efficacy of N-acetylcysteine in preventing amphotericin B induced acute kidney injury</title><title>Marmara Medical Journal</title><description>Objectives: Previously, in an animal study we showed that N-acetylcysteine (NAC) could decrease deoxycholate amphotericin B (DAmB) induced renal tubular apoptosis. In this clinical study, we aimed to evaluate the efficacy of NAC in preventing acute kidney injury (AKI) in febrile neutropenic patients with invasive pulmonary aspergillosis treated with DAmB.Patients and Methods: Thirty-three patients were included in the study. 17 patients were randomly placed into the DAmB group and 16 were randomly placed into the DAmB plus NAC group.Results: The characteristics of patients, durations and cumulative doses of DAmB, concurrent nephrotoxic drugs and basal serum creatinine (SCr) levels of patients were similar. Occurrence of a 1.5 fold or greater increase in the concentration of basal SCr and serum electrolytes were observed prospectively. The overall AKI was found in 13 patients (76.4%) in DAmB group and 6 patients (37.5%) in combination group (P = 0.024). No significant difference was observed in hypokalemia incidence between the groups (87.5 % in combination vs. 94.1 % in DAmB only groups).Conclusion: This clinical pilot study showed that NAC may be a promising anti-oxidant agent to decrease DAmB-induced AKI in febrile neutropenic patients.Keywords: Amphotericin</description><subject>Kidneys</subject><subject>Neutropenia</subject><issn>1019-1941</issn><issn>1309-9469</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNotkEtPwzAQhC0EEqVw5G6Js4sfsRMfoSovtXChZ8tx1uDQJsFxkPLvSSmnWc2MdqQPoWtGFzLL-e1m89LaBdeULyg_QTMmqCY6U_p0uinThOmMnaOLvq8plQXVaoa2K--Ds27ErcevxDpI486NfYLQAA4N7iL8QJNC84HtvvtsE8TgJv9-CqvBQYWtGxLgr1A1ME5mPcTxEp15u-vh6l_naPuwel8-kfXb4_Pybk0cVzQR4LagEqTMfQbUilJXkGsnQChlZVEWEpwHpWSpla1KKyXkTGSMVZktS1uIObo5_u1i-z1An0zdDrGZJg3PWZELxriaWuTYcrHt-wjedDHsbRwNo-ZAzvyRMwdyhnLxC_NiYqQ</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Erturk Sengel, Buket</creator><creator>Tukenmez Tigen, Elif</creator><creator>Toptas, Tayfur</creator><creator>Atagunduz, Isik</creator><creator>Tuglular, Ayse Tulin</creator><creator>Ergönül, Mehmet Onder</creator><creator>Odabası, Zekaver</creator><general>Marmara University</general><scope>AAYXX</scope><scope>CITATION</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20160101</creationdate><title>Efficacy of N-acetylcysteine in preventing amphotericin B induced acute kidney injury</title><author>Erturk Sengel, Buket ; Tukenmez Tigen, Elif ; Toptas, Tayfur ; Atagunduz, Isik ; Tuglular, Ayse Tulin ; Ergönül, Mehmet Onder ; Odabası, Zekaver</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260t-e2a805e557f4e0a3b9de79c3e366a58b85ecfe665b96adba55e713411d4abba83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Kidneys</topic><topic>Neutropenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Erturk Sengel, Buket</creatorcontrib><creatorcontrib>Tukenmez Tigen, Elif</creatorcontrib><creatorcontrib>Toptas, Tayfur</creatorcontrib><creatorcontrib>Atagunduz, Isik</creatorcontrib><creatorcontrib>Tuglular, Ayse Tulin</creatorcontrib><creatorcontrib>Ergönül, Mehmet Onder</creatorcontrib><creatorcontrib>Odabası, Zekaver</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Marmara Medical Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Erturk Sengel, Buket</au><au>Tukenmez Tigen, Elif</au><au>Toptas, Tayfur</au><au>Atagunduz, Isik</au><au>Tuglular, Ayse Tulin</au><au>Ergönül, Mehmet Onder</au><au>Odabası, Zekaver</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of N-acetylcysteine in preventing amphotericin B induced acute kidney injury</atitle><jtitle>Marmara Medical Journal</jtitle><date>2016-01-01</date><risdate>2016</risdate><volume>29</volume><issue>2</issue><spage>73</spage><pages>73-</pages><issn>1019-1941</issn><eissn>1309-9469</eissn><abstract>Objectives: Previously, in an animal study we showed that N-acetylcysteine (NAC) could decrease deoxycholate amphotericin B (DAmB) induced renal tubular apoptosis. In this clinical study, we aimed to evaluate the efficacy of NAC in preventing acute kidney injury (AKI) in febrile neutropenic patients with invasive pulmonary aspergillosis treated with DAmB.Patients and Methods: Thirty-three patients were included in the study. 17 patients were randomly placed into the DAmB group and 16 were randomly placed into the DAmB plus NAC group.Results: The characteristics of patients, durations and cumulative doses of DAmB, concurrent nephrotoxic drugs and basal serum creatinine (SCr) levels of patients were similar. Occurrence of a 1.5 fold or greater increase in the concentration of basal SCr and serum electrolytes were observed prospectively. The overall AKI was found in 13 patients (76.4%) in DAmB group and 6 patients (37.5%) in combination group (P = 0.024). No significant difference was observed in hypokalemia incidence between the groups (87.5 % in combination vs. 94.1 % in DAmB only groups).Conclusion: This clinical pilot study showed that NAC may be a promising anti-oxidant agent to decrease DAmB-induced AKI in febrile neutropenic patients.Keywords: Amphotericin</abstract><cop>Istanbul</cop><pub>Marmara University</pub><doi>10.5472/MMJoa.2902.02</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1019-1941 |
| ispartof | Marmara Medical Journal, 2016-01, Vol.29 (2), p.73 |
| issn | 1019-1941 1309-9469 |
| language | eng |
| recordid | cdi_proquest_journals_2718731126 |
| source | EZB Electronic Journals Library |
| subjects | Kidneys Neutropenia |
| title | Efficacy of N-acetylcysteine in preventing amphotericin B induced acute kidney injury |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T13%3A54%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20N-acetylcysteine%20in%20preventing%20amphotericin%20B%20induced%20acute%20kidney%20injury&rft.jtitle=Marmara%20Medical%20Journal&rft.au=Erturk%20Sengel,%20Buket&rft.date=2016-01-01&rft.volume=29&rft.issue=2&rft.spage=73&rft.pages=73-&rft.issn=1019-1941&rft.eissn=1309-9469&rft_id=info:doi/10.5472/MMJoa.2902.02&rft_dat=%3Cproquest_cross%3E2718731126%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2718731126&rft_id=info:pmid/&rfr_iscdi=true |